Back to results
RecruitingPhase 2

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer

NCT04159142

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The Fourth Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Contact

Cuizhi Geng, M.D.

0311-6669 6310gengcuizhi@hotmail.com
View on ClinicalTrials.gov
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer — TrialFind